Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?
Clinical trial NCT02286843 · COMPLETED
Trial details
- NCT number
- NCT02286843
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-06
- Primary completion
- 2020-06-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.